Dr. Franklyn Prendergast joins NRI’s Advisory Board
NRI’s advisory board is comprised of an esteemed and diverse group of leading academics and authorities, who work with our leadership team to ensure NRI remains at the forefront of trends that shape our industry.
“We are very fortunate to have proven leaders to help expand our expertise and support us to meet challenges as we continue to grow. It is with great excitement and honor that we are proud to announce that Franklyn G. Prendergast, M.D., Ph.D. has joined NRI Advisory Board.” – Brent Reynolds CEO & Managing Partner
Throughout his 50+ year career as a healthcare practitioner, administrator, and innovator, Dr. Prendergast has greatly influenced the direction of healthcare and medical sciences research providing strategic guidance to health institutions in the United States and around the globe including the Saudi Ministry of Health. Dr. Prendergast has also served on the Board of Directors of the Infectious Disease Research Institute (IDRI) for more than 15 years, and has worked extensively for the National Institutes of Health on numerous study section review groups.
“Dr. Prendergast’s depth of experience and knowledge in the healthcare industry and detailed evaluation approach will help us as we shape the future of NRI.” – Brent Reynolds CEO and Managing Partner
